As spring farming begins across the country, China released its annual rural policy blueprint on Sunday, referred to as the ...

Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.

A person’s precious organ donation came with an unexpected visitor. In a new paper out this month, scientists have documented ...

Since 2013, diagnoses of multiple sclerosis (MS) in Finland take less time after symptom onset and treatments follow the ...

Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrome relapsing in a phase 3 trial, setting the ...

Losing weight isn’t just about cutting calories—it’s a comprehensive health journey. Dr. Bharti Shetye, also known as Dr.

Daughter’s school sports day led to man’s heartbreaking incurable diagnosis - The 44-year-old hopes to travel to Mexico in ...

An Oklahoma house bill for patients' rights cleared a hurdle at the capital on Monday. The measure would ensure people are treated safely and that their family is kept informed at medical facilities.

TG Therapeutics (NASDAQ:TGTX – Get Free Report) is expected to be releasing its earnings data before the market opens on Wednesday, February 26th. Analysts expect TG Therapeutics to post earnings of ...

Immunic (NASDAQ:IMUX – Get Free Report) is anticipated to post its quarterly earnings results before the market opens on Thursday, February 27th. Analysts expect Immunic to post earnings of ($0.22) ...

The policy blueprint recently unveiled by the central authorities for agricultural and rural development is expected to give ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for dupilumab to treat adults with bullous pemphigoid.